Our offering
Alzheimer's Disease
Ncyte® Neural Mix or hiPSC-microglia
Parkinson's Disease
hiPSC-dopaminergic neurons
ALS / FTD
hiPSC-derived motor neurons
Neuroinflammation
Co-culture of hiPSC-derived neurons with astrocytes or microglia
Cardiac Hypertrophy
Ncyte® vCardiomyocytes
Gene Modulation
Cell model of your choice
Neurotoxicity
hiPSC-derived model of your choice
Cardiotoxicity
hiPSC-derived cardiomyocytes
Endothelial Barrier Function
Ncyte® Endothelial Cells
3D Cardiac Microtissues
Cardiac microtissues with hiPSC-derived ventricular cardiomyocytes, endothelial cells, and cardiac fibroblasts
3D Mature Neurospheres
Coming Soon
Alzheimer's Disease
| Readout | Technology |
|---|---|
| Phosphorylated TAU | High Content Imaging |
| MC-1 soluble TAU aggregates | |
| Insoluble TAU aggregates | |
| Proteasomal Activity | |
| Neurite growth | |
| Cytokine release | MSD, HTRF, ELISA |
| Electrophysiology | MEA |
Are you interested on this screening assay?
Request InformationAre you looking for a custom solution?
Contact Us
Scientific poster: A human iPSC-based platform to screen therapeutics for ALS using specific and robust phenotypic assays covering disease relevant readouts.
Scientific poster: Development of a robust and scalable iPSC platform for predictions of efficacy and in vivo toxicity of RNA therapeutics in the drug discovery pipeline
Scientific poster: Development of robust iPSC-based a-Synuclein, TAU and TDP-43 aggregation models for drug discovery